NEF PROTEIN OF HIV-1 HAS B-CELL STIMULATORY ACTIVITY

被引:35
作者
CHIRMULE, N [1 ]
OYAIZU, N [1 ]
SAXINGER, C [1 ]
PAHWA, S [1 ]
机构
[1] NCI,TUMOR CELL BIOL LAB,BETHESDA,MD
关键词
NEF; INTERLEUKIN-6; B-CELL DIFFERENTIATION; T-B-CELL CONTACT;
D O I
10.1097/00002030-199406000-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To examine the B-cell stimulatory properties of the regulatory Nef protein of HIV-1. Methods: The effect of the HIV-1 regulatory proteins Nef, Tat and Vif, were analyzed for their ability to induce differentiation of normal B lymphocytes into immunoglobulin secreting cells (ISC). Results: A recombinant Nei protein, but neither Tat or Vif, was able to induce ISC in peripheral blood lymphocyte (PBL) cultures of HIV-1-seronegative donors. Another recombinant Nef protein, d-Nef, with a truncated amino terminal (deletion of 34 amino acids) failed to induce B-cell differentiation. Pretreatment of the Nef protein with a polyclonal anti-Nef-antibody abrogated its B-cell stimulatory activity. The Nef-induced B-cell differentiation was dependent on cell-to-cell contact. Cell surface molecules leukocyte function-associated molecule (LFA)-1, intracellular adhesion molecule (ICAM)-1, human lymphocyte antigen-DR and B7 were involved in the T-B-cell interaction because monoclonal antibodies to these molecules abrogated the Nef-induced B-cell differentiation response. The Nef protein was able to induce interleukin (IL)-6 messenger (m)RNA and IL-6 protein secretion in PBL, with monocytes as the primary source. Conclusions: These findings indicate that regulatory (Nef) proteins of HIV-1 contribute to the intense B-cell activation that occurs in association with HIV-1 infection. T-B-cell contact-dependent interaction and induction of IL-6 by these proteins appear to play major roles in this process.
引用
收藏
页码:733 / 739
页数:7
相关论文
共 38 条
[21]  
KOENIG S, 1990, J IMMUNOL, V145, P127
[22]   ABNORMALITIES OF B-CELL ACTIVATION AND IMMUNOREGULATION IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
LANE, HC ;
MASUR, H ;
EDGAR, LC ;
WHALEN, G ;
ROOK, AH ;
FAUCI, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (08) :453-458
[23]   EXPRESSION OF THE TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS NEF PROTEIN IN T-CELLS PREVENTS ANTIGEN RECEPTOR-MEDIATED INDUCTION OF INTERLEUKIN-2 MESSENGER-RNA [J].
LURIA, S ;
CHAMBERS, I ;
BERG, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5326-5330
[24]  
MARTINEZMAZA O, 1987, J IMMUNOL, V138, P3720
[25]   SIGNALING THROUGH THE MHC CLASS-II CYTOPLASMIC DOMAIN IS REQUIRED FOR ANTIGEN PRESENTATION AND INDUCES B7 EXPRESSION [J].
NABAVI, N ;
FREEMAN, GJ ;
GAULT, A ;
GODFREY, D ;
NADLER, LM ;
GLIMCHER, LH .
NATURE, 1992, 360 (6401) :266-268
[26]  
NAIR MPN, 1988, P NATL ACAD SCI USA, V83, P6498
[27]  
NAKAJIMA K, 1989, J IMMUNOL, V142, P531
[28]   HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 NEGATIVE FACTOR IS A TRANSCRIPTIONAL SILENCER [J].
NIEDERMAN, TMJ ;
THIELAN, BJ ;
RATNER, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) :1128-1132
[29]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN INHIBITS NF-KAPPA-B INDUCTION IN HUMAN T-CELLS [J].
NIEDERMAN, TMJ ;
GARCIA, JV ;
HASTINGS, WR ;
LURIA, S ;
RATNER, L .
JOURNAL OF VIROLOGY, 1992, 66 (10) :6213-6219
[30]  
NOELLE RJ, 1990, IMMUNOL TODAY, V11, P1